CRC incidence in UC after 10 years

What is known

• In ulcerative colitis, the risk of colorectal cancer becomes appreciable after about 10 years of disease, and a 2001 meta-analysis reported that the annual incidence rate rose across decades of disease, roughly 2 per 1000 person-years in the first decade, 7 per 1000 in the second decade, and 12 per 1000 in the third decade. ¹
• Those 2001 pooled rates came predominantly from referral and tertiary-centre series collected between the 1950s and 2000, and are now widely regarded as an overestimate of contemporary risk. Population-based cohorts and pooled analyses published since 2012 report roughly 1% cumulative colorectal cancer risk at 10 years, 2% at 20 years and 5% beyond 20 years, roughly 2 to 4 fold lower than the older figures, attributed to surveillance colonoscopy, wider mucosal healing on maintenance therapy and earlier colectomy.
• For disease lasting more than ten years, the older pooled figure is on the order of about 7 per 1000 person-years (~0.7%), rising as duration lengthens; contemporary population-based estimates are appreciably lower and should be used when counselling a patient. ¹

What is unknown / caveats

• The incidence is reported in decade bands rather than as a single annual rate for disease lasting more than ten years; the figure quoted for that window is given as an approximation ("on the order of") rather than a directly reported value.
• The rate is not described as constant beyond ten years. It rises further as duration lengthens, so one annual figure does not characterise the whole period.

References

1. Sebastian S, Hernández V, Myrelid P, Kariv R, Tsianos E, Toruner M, Marti-Gallostra M, Spinelli A, van der Meulen-de Jong AE, Yuksel ES, Gasche C, Ardizzone S, Danese S. Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I). J Crohns Colitis. 2014;8(1):5-18. PMID: 23664897.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.